The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Botulinum Type B Market Research Report 2024

Global Botulinum Type B Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1745699

No of Pages : 99

Synopsis
Botulinum Type B is a strain of the botulinum toxin produced by the anaerobic bacterium Clostridium botulinum. Botulinum Type B has been shown to be effective in treating conditions such as cervical dystonia, a neurological disorder characterized by involuntary muscle contractions in the neck, and sialorrhea, or excessive drooling. It is also used to treat cosmetic concerns such as wrinkles and fine lines.

Global Botulinum Type B market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Botulinum Type B market research.

Key manufacturers engaged in the Botulinum Type B industry include Ipsen, Hugel, Inibio, Galderma, Allergan, Medytox, Merz Pharmaceuticals, Daewoong Pharmaceutical and Huadong Medicine, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Botulinum Type B were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Botulinum Type B market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Botulinum Type B market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Ipsen
  • Hugel
  • Inibio
  • Galderma
  • Allergan
  • Medytox
  • Merz Pharmaceuticals
  • Daewoong Pharmaceutical
  • Huadong Medicine
  • Sihuan Pharmaceutical Holdings Group

Segment by Type

  • 25 Units
  • 50 Units
  • Others

Segment by Application

  • Medical
  • Cosmetic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Botulinum Type B report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Botulinum Type B Market Overview
1.1 Product Overview and Scope of Botulinum Type B
1.2 Botulinum Type B Segment by Type
1.2.1 Global Botulinum Type B Market Value Comparison by Type (2023-2029)
1.2.2 25 Units
1.2.3 50 Units
1.2.4 Others
1.3 Botulinum Type B Segment by Application
1.3.1 Global Botulinum Type B Market Value by Application: (2023-2029)
1.3.2 Medical
1.3.3 Cosmetic
1.4 Global Botulinum Type B Market Size Estimates and Forecasts
1.4.1 Global Botulinum Type B Revenue 2018-2029
1.4.2 Global Botulinum Type B Sales 2018-2029
1.4.3 Global Botulinum Type B Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Botulinum Type B Market Competition by Manufacturers
2.1 Global Botulinum Type B Sales Market Share by Manufacturers (2018-2023)
2.2 Global Botulinum Type B Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Botulinum Type B Average Price by Manufacturers (2018-2023)
2.4 Global Botulinum Type B Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Botulinum Type B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Botulinum Type B, Product Type & Application
2.7 Botulinum Type B Market Competitive Situation and Trends
2.7.1 Botulinum Type B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Botulinum Type B Players Market Share by Revenue
2.7.3 Global Botulinum Type B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Botulinum Type B Retrospective Market Scenario by Region
3.1 Global Botulinum Type B Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Botulinum Type B Global Botulinum Type B Sales by Region: 2018-2029
3.2.1 Global Botulinum Type B Sales by Region: 2018-2023
3.2.2 Global Botulinum Type B Sales by Region: 2024-2029
3.3 Global Botulinum Type B Global Botulinum Type B Revenue by Region: 2018-2029
3.3.1 Global Botulinum Type B Revenue by Region: 2018-2023
3.3.2 Global Botulinum Type B Revenue by Region: 2024-2029
3.4 North America Botulinum Type B Market Facts & Figures by Country
3.4.1 North America Botulinum Type B Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Botulinum Type B Sales by Country (2018-2029)
3.4.3 North America Botulinum Type B Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Botulinum Type B Market Facts & Figures by Country
3.5.1 Europe Botulinum Type B Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Botulinum Type B Sales by Country (2018-2029)
3.5.3 Europe Botulinum Type B Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Botulinum Type B Market Facts & Figures by Country
3.6.1 Asia Pacific Botulinum Type B Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Botulinum Type B Sales by Country (2018-2029)
3.6.3 Asia Pacific Botulinum Type B Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Botulinum Type B Market Facts & Figures by Country
3.7.1 Latin America Botulinum Type B Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Botulinum Type B Sales by Country (2018-2029)
3.7.3 Latin America Botulinum Type B Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Botulinum Type B Market Facts & Figures by Country
3.8.1 Middle East and Africa Botulinum Type B Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Botulinum Type B Sales by Country (2018-2029)
3.8.3 Middle East and Africa Botulinum Type B Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Botulinum Type B Sales by Type (2018-2029)
4.1.1 Global Botulinum Type B Sales by Type (2018-2023)
4.1.2 Global Botulinum Type B Sales by Type (2024-2029)
4.1.3 Global Botulinum Type B Sales Market Share by Type (2018-2029)
4.2 Global Botulinum Type B Revenue by Type (2018-2029)
4.2.1 Global Botulinum Type B Revenue by Type (2018-2023)
4.2.2 Global Botulinum Type B Revenue by Type (2024-2029)
4.2.3 Global Botulinum Type B Revenue Market Share by Type (2018-2029)
4.3 Global Botulinum Type B Price by Type (2018-2029)
5 Segment by Application
5.1 Global Botulinum Type B Sales by Application (2018-2029)
5.1.1 Global Botulinum Type B Sales by Application (2018-2023)
5.1.2 Global Botulinum Type B Sales by Application (2024-2029)
5.1.3 Global Botulinum Type B Sales Market Share by Application (2018-2029)
5.2 Global Botulinum Type B Revenue by Application (2018-2029)
5.2.1 Global Botulinum Type B Revenue by Application (2018-2023)
5.2.2 Global Botulinum Type B Revenue by Application (2024-2029)
5.2.3 Global Botulinum Type B Revenue Market Share by Application (2018-2029)
5.3 Global Botulinum Type B Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ipsen
6.1.1 Ipsen Corporation Information
6.1.2 Ipsen Description and Business Overview
6.1.3 Ipsen Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ipsen Botulinum Type B Product Portfolio
6.1.5 Ipsen Recent Developments/Updates
6.2 Hugel
6.2.1 Hugel Corporation Information
6.2.2 Hugel Description and Business Overview
6.2.3 Hugel Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hugel Botulinum Type B Product Portfolio
6.2.5 Hugel Recent Developments/Updates
6.3 Inibio
6.3.1 Inibio Corporation Information
6.3.2 Inibio Description and Business Overview
6.3.3 Inibio Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Inibio Botulinum Type B Product Portfolio
6.3.5 Inibio Recent Developments/Updates
6.4 Galderma
6.4.1 Galderma Corporation Information
6.4.2 Galderma Description and Business Overview
6.4.3 Galderma Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Galderma Botulinum Type B Product Portfolio
6.4.5 Galderma Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Allergan Botulinum Type B Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 Medytox
6.6.1 Medytox Corporation Information
6.6.2 Medytox Description and Business Overview
6.6.3 Medytox Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medytox Botulinum Type B Product Portfolio
6.6.5 Medytox Recent Developments/Updates
6.7 Merz Pharmaceuticals
6.6.1 Merz Pharmaceuticals Corporation Information
6.6.2 Merz Pharmaceuticals Description and Business Overview
6.6.3 Merz Pharmaceuticals Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merz Pharmaceuticals Botulinum Type B Product Portfolio
6.7.5 Merz Pharmaceuticals Recent Developments/Updates
6.8 Daewoong Pharmaceutical
6.8.1 Daewoong Pharmaceutical Corporation Information
6.8.2 Daewoong Pharmaceutical Description and Business Overview
6.8.3 Daewoong Pharmaceutical Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Daewoong Pharmaceutical Botulinum Type B Product Portfolio
6.8.5 Daewoong Pharmaceutical Recent Developments/Updates
6.9 Huadong Medicine
6.9.1 Huadong Medicine Corporation Information
6.9.2 Huadong Medicine Description and Business Overview
6.9.3 Huadong Medicine Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huadong Medicine Botulinum Type B Product Portfolio
6.9.5 Huadong Medicine Recent Developments/Updates
6.10 Sihuan Pharmaceutical Holdings Group
6.10.1 Sihuan Pharmaceutical Holdings Group Corporation Information
6.10.2 Sihuan Pharmaceutical Holdings Group Description and Business Overview
6.10.3 Sihuan Pharmaceutical Holdings Group Botulinum Type B Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sihuan Pharmaceutical Holdings Group Botulinum Type B Product Portfolio
6.10.5 Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Botulinum Type B Industry Chain Analysis
7.2 Botulinum Type B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Botulinum Type B Production Mode & Process
7.4 Botulinum Type B Sales and Marketing
7.4.1 Botulinum Type B Sales Channels
7.4.2 Botulinum Type B Distributors
7.5 Botulinum Type B Customers
8 Botulinum Type B Market Dynamics
8.1 Botulinum Type B Industry Trends
8.2 Botulinum Type B Market Drivers
8.3 Botulinum Type B Market Challenges
8.4 Botulinum Type B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’